CGB 0.00% 2.1¢ cann global limited

Ann: MCL Implementing Canntab Drug Development Strategy, page-9

  1. 128 Posts.
    lightbulb Created with Sketch. 48
    I do agree Iwonder.
    Look at Medlab with there nanocelle delivery method, nanabis product and the time these things take. Yes they had cash flows last qtr, $498 maybe they will beat it next qtr?
 
watchlist Created with Sketch. Add CGB (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.